Stock Groups

Becton Dickinson Earnings, Revenue Beat in Q4 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Becton Dickinson Reports Q4 Revenue Beat, Earnings

Becton Dixon (NYSE:), reported Thursday that the fourth quarter beat forecasts by analysts and that revenue was higher than expected.

Becton Dickinson posted earnings per share in the range of $2.59 to $5.14B on revenues of $5.14B. Investing.com polled analysts and predicted EPS at $2.45 for revenue of $4.91B.

Becton Dickinson shares have fallen 1% since the start of the year. However, they are still 7.61% below their 52-week high of $267.37 on January 12. They are under-performing the S&P 500 which is up 24.08% from the start of the year.

Becton Dickinson joins other top Healthcare sector earnings for this month

Becton Dickinson’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific beat all expectations with a third quarter EPS at $5.76 on revenues of $9.33B. This compares to a forecast of EPS at $4.68 for revenue of $8.38B.

You can keep up to date on the latest earnings reports at www.investors.com Investing.com’s earnings calendar

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]